Abstract
We evaluated the efficacy of testing pooled versus individual sera for the detection of human immunodeficiency virus antibody. A total of 5,000 individual specimens and 500 pools of 10 specimens each were assayed by an enzyme-linked immunosorbent assay. There was complete agreement in human immunodeficiency virus enzyme-linked immunosorbent assay reactivity for pooled versus individual specimens. An estimated savings of 60 to 80% (labor and supplies) can be realized dependent upon pooling and assay format.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Borkowsky W., Krasinski K., Paul D., Moore T., Bebenroth D., Chandwani S. Human-immunodeficiency-virus infections in infants negative for anti-HIV by enzyme-linked immunoassay. Lancet. 1987 May 23;1(8543):1168–1171. doi: 10.1016/s0140-6736(87)92143-x. [DOI] [PubMed] [Google Scholar]
- Bove J. R., DePalma L., Weirich F. Anti-HTLV-III/LAV in pooled sera. Clin Chem. 1987 Feb;33(2 Pt 1):308–308. [PubMed] [Google Scholar]
- Burkhardt U., Mertens T., Eggers H. J. Comparison of two commercially available anti-HIV ELISAs: Abbott HTLV III EIA and Du Pont HTLV III-ELISA. J Med Virol. 1987 Nov;23(3):217–224. doi: 10.1002/jmv.1890230303. [DOI] [PubMed] [Google Scholar]
- Carlson J. R., Bryant M. L., Hinrichs S. H., Yamamoto J. K., Levy N. B., Yee J., Higgins J., Levine A. M., Holland P., Gardner M. B. AIDS serology testing in low- and high-risk groups. JAMA. 1985 Jun 21;253(23):3405–3408. [PubMed] [Google Scholar]
- Courouce A. M. Evaluation of eight ELISA kits for the detection of anti-LAV/HTLV-III antibodies. Lancet. 1986 May 17;1(8490):1152–1153. doi: 10.1016/s0140-6736(86)91863-5. [DOI] [PubMed] [Google Scholar]
- Gallo D., Diggs J. L., Shell G. R., Dailey P. J., Hoffman M. N., Riggs J. L. Comparison of detection of antibody to the acquired immune deficiency syndrome virus by enzyme immunoassay, immunofluorescence, and Western blot methods. J Clin Microbiol. 1986 Jun;23(6):1049–1051. doi: 10.1128/jcm.23.6.1049-1051.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gocke D. J., Raska K., Jr, Pollack W., Schwartzer T. HTLV-III antibody in commercial immunoglobulin. Lancet. 1986 Jan 4;1(8471):37–38. doi: 10.1016/s0140-6736(86)91914-8. [DOI] [PubMed] [Google Scholar]
- Houn H. Y., Pappas A. A., Walker E. M., Jr Status of current clinical tests for human immunodeficiency virus (HIV): applications and limitations. Ann Clin Lab Sci. 1987 Sep-Oct;17(5):279–285. [PubMed] [Google Scholar]
- Howanitz P. J., McBride J. H., Kliewer K. E., Rodgerson D. O. Prevalence of antibodies to HTLV-III in quality-assurance sera. Clin Chem. 1986 May;32(5):773–777. [PubMed] [Google Scholar]
- Johnson J. E. Use of a commercial ELISA test for the diagnosis of infection by the AIDS virus, HIV, in a patient population. Diagn Microbiol Infect Dis. 1987 Mar;6(3):267–271. doi: 10.1016/0732-8893(87)90022-8. [DOI] [PubMed] [Google Scholar]
- Köller U., Rumpold H., Schindler J., Schweiger C., Gabl F. Incidence of anti HIV antibodies and viral antigen in standard and control sera. J Clin Chem Clin Biochem. 1987 Oct;25(10):705–709. doi: 10.1515/cclm.1987.25.10.705. [DOI] [PubMed] [Google Scholar]
- Lennette E. T., Karpatkin S., Levy J. A. Indirect immunofluorescence assay for antibodies to human immunodeficiency virus. J Clin Microbiol. 1987 Feb;25(2):199–202. doi: 10.1128/jcm.25.2.199-202.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ozanne G., Fauvel M. Performance and reliability of five commercial enzyme-linked immunosorbent assay kits in screening for anti-human immunodeficiency virus antibody in high-risk subjects. J Clin Microbiol. 1988 Aug;26(8):1496–1500. doi: 10.1128/jcm.26.8.1496-1500.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]